TrialBlood2023
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
Ryan C Lynch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled ittrialcites it
TrialBlood2023
Ryan C Lynch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.